Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
New Class Of Drug Raises Hope For Blood Cancer Patients
NEW YORK.
Flexion's pain drug succeeds in study, shares soar
Flexion Therapeutics Inc's pain drug was found to be effective in a late-stage study, taking the company one step closer to its first ever U.
WHO seeks $56 million for plan to combat Zika virus
The World Health Organization (WHO) said on Wednesday that $56 million would be needed until June to fund a strategy to combat the Zika virus which has spread to 39 countries and has been link...
U.S. FDA Approves Two Supplemental Indications for Harvoni® in Chronic Hepatitis C Patients With Advanced Liver Disease
FOSTER CITY, Calif.
Pfizer to Pay $785 Million to Settle Medicaid Claims
Drugmaker Pfizer Inc.
US FDA refuses to approve Merck's Zetia and Vytorin medicines
Zetiia VytorinThe US Food and Drug Administration (...
Biocon's Rosuvastatin Calcium tablets get EU approval to treat hyperlipidemia
Indian biopharmaceutical company Biocon has received approval from the European Commission for its Rosuvastatin Calcium tablets to treat hyperlipidemia or mixed dyslipidemia.
Sun Pharma calls off Merck deal
Our Special Correspondent, Mumbai.
FDA grants orphan status for Amarantus' eltoprazine to treat PD-LID
The US Food and Drug Administration (FDA) has granted orphan drug designation for Amarantus BioScience Holdings' (AMBS') eltoprazine to treat Parkinson's disease levodopa-i...
Glaxo fined £37.6m for 'illegal behaviour' over Seroxat deals
GlaxoSmithKline has been fined £37.
Teva Shares Plunge as Sales of Copaxone Disappoint
Teva Pharmaceutical Industries Ltd.
Nanoparticle reduces targeted cancer drug's toxicity
The polymeric nanoparticle Accurin encapsulates the clinical candidate AZD2811, an Aurora B kinase inhibitor.
627
628
629
630
631
632
633
634
635
